Exclusive

Publication

Byline

Imugene and JW Therapeutics to bring CD19 CAR-T innovation for solid tumours

Singapore, Nov. 28 -- Australia's Imugene has entered a strategic co-development collaboration with Chinese startup JW Therapeutics to evaluate a novel combination immunotherapy for patients with adva... Read More


Korea's SK Biopharmaceuticals expands radiopharmaceutical therapy portfolio

Singapore, Nov. 28 -- SK Biopharmaceuticals, a South Korea-based biotech company specialising in research, development, and commercialisation of treatments for central nervous system (CNS) disorders a... Read More


Singapore's Patronus Biotech receives grant to evaluate novel malaria vaccine and adjuvant

Singapore, Nov. 28 -- Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development of its novel malaria vaccine and adjuvant programme to supp... Read More


US FDA approves Novartis' gene therapy for treatment of spinal muscular atrophy

Singapore, Nov. 28 -- The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and paediatric patients... Read More


Hikma partners with DGI Group to bring Claritag(R) to MENA region's dermatology sector

Singapore, Nov. 27 -- Hikma Pharmaceuticals PLC,the multinational pharmaceutical company, has signed an exclusive licensing agreement with DGI Group LLC, a US-based company specialising in professiona... Read More


Polarean expands commercial reach and advances lung imaging innovation in Asia-Pacific

Singapore, Nov. 27 -- US-based Polarean Imaging plc, a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (MRI) of the lungs, has signed an exclusive distribut... Read More


Precious Medical Group invests RM500 M for advanced cancer care infrastructure in Malaysia

Singapore, Nov. 27 -- Singapore-based healthcare provider Precious Medical Group has announced the launch of theTunku Laksamana Johor Cancer Centre and Hospital, a landmark RM500 million development f... Read More


Singapore's Prestige Biopharma to commercialise cancer drug Tuznue(R) in Latin America

Singapore, Nov. 26 -- Singapore headquartered Prestige Biopharma, a biopharmaceutical company specialising in antibody therapeutics, has announced an exclusive license and supply agreement with Biosid... Read More


Korean startup Neurophet advances Alzheimer's Disease diagnosis in partnership with The Florey Strengthen Research

Singapore, Nov. 25 -- South Korea-based Neurophet, an artificial intelligence (AI) solution startup for brain disorders diagnosis and treatment, is collaborating with the Florey Institute of Neuroscie... Read More


Algorithm and Batterjee Pharma sign agreement to localise key pharmaceuticals in Saudi Arabia

Singapore, Nov. 25 -- Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical ... Read More